Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the US in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
62 companies reporting in the next 90 days. Clear filters
Data as of Aug 26, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Thursday, Aug 27 · Earnings today · 1 company | |||||
| PRTC.L | PureTech Health plc | Oncology | $402.61M | +0.51% | |
| Wednesday, Sep 9 · in 13 days · 1 company | |||||
| ANIX | Anixa Biosciences, Inc. | Oncology | $123.16M | +5.78% | |
| Monday, Oct 19 · in 53 days · 1 company | |||||
| SMMT | Summit Therapeutics Inc. | Oncology | $10.66B | +1.95% | |
| Tuesday, Oct 27 · in 61 days · 4 companies | |||||
| INCY | Incyte Corporation | ||||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| $26.29B |
| +9.13% |
| 0J9P.L | Incyte Corporation | Oncology | $21.10B | +1.97% |
| EXEL | Exelixis, Inc. | Oncology | $14.05B | +1.63% |
| 0IJO.L | Exelixis, Inc. | Oncology | $14.05B | +3.33% |
| Wednesday, Oct 28 · in 62 days · 1 company | |||||
| 0KCS.L | OPKO Health, Inc. | Oncology | $578.38M | +2.03% | |
| Thursday, Oct 29 · in 63 days · 1 company | |||||
| BMY | Bristol-Myers Squibb Company | Oncology | $138.74B | +8.57% | |
| Monday, Nov 2 · in 67 days · 2 companies | |||||
| SNDX | Syndax Pharmaceuticals, Inc. | Oncology | $1.77B | −2.92% | |
| PYXS | Pyxis Oncology, Inc. | Oncology | $255.23M | +5.15% | |
| Tuesday, Nov 3 · in 68 days · 7 companies | |||||
| CRVS | Corvus Pharmaceuticals, Inc. | Oncology | $1.22B | +12.69% | |
| KURA | Kura Oncology, Inc. | Oncology | $1.10B | +33.89% | |
| RIGL | Rigel Pharmaceuticals, Inc. | Oncology | $864.97M | +25.03% | |
| NVCT | Nuvectis Pharma, Inc. | Oncology | $777.72M | +32.50% | |
| VSTM | Verastem, Inc. | Oncology | $641.19M | +16.45% | |
| DCTH | Delcath Systems, Inc. | Oncology | $587.10M | +41.71% | |
| 0LOV.L | Verastem, Inc. | Oncology | $470.33M | +3.48% | |
| Wednesday, Nov 4 · in 69 days · 5 companies | |||||
| RVMD | Revolution Medicines, Inc. | Oncology | $45.35B | +12.39% | |
| VIR | Vir Biotechnology, Inc. | Oncology | $1.81B | +21.70% | |
| GERN | Geron Corporation | Oncology | $995.83M | +4.73% | |
| ARVN | Arvinas, Inc. | Oncology | $610.71M | +16.79% | |
| 0IV3.L | Geron Corporation | Oncology | $255.34M | 0.00% | |
| Thursday, Nov 5 · in 70 days · 16 companies | |||||
| ZYME | Zymeworks Inc. | Oncology | $1.96B | +19.43% | |
| DMRA | Damora Therapeutics, Inc. | Oncology | $1.89B | +4.01% | |
| REPL | Replimune Group, Inc. | Oncology | $1.49B | +83.08% | |
| CGEM | Cullinan Therapeutics, Inc. | Oncology | $1.48B | +31.67% | |
| GLUE | Monte Rosa Therapeutics, Inc. | Oncology | $1.24B | −35.46% | |
| JANX | Janux Therapeutics, Inc. | Oncology | $1.14B | +19.97% | |
| CTMX | CytomX Therapeutics, Inc. | Oncology | $734.32M | +3.69% | |
| CCCC | C4 Therapeutics, Inc. | Oncology | $516.71M | +16.99% | |
| PBYI | Puma Biotechnology, Inc. | Oncology | $470.77M | +16.65% | |
| CMPX | Compass Therapeutics, Inc. | Oncology | $455.62M | +21.63% | |
| FHTX | Foghorn Therapeutics Inc. | Oncology | $406.79M | +31.73% | |
| AGEN | Agenus Inc. | Oncology | $376.28M | +36.38% | |
| 0XOD.L | UroGen Pharma Ltd. | Oncology | $347.24M | −1.31% | |
| WHWK | Whitehawk Therapeutics, Inc. | Oncology | $278.20M | +37.30% | |
| CHRS | Coherus Oncology, Inc. | Oncology | $211.67M | −6.16% | |
| BDTX | Black Diamond Therapeutics, Inc. | Oncology | $123.81M | +29.48% | |
| Friday, Nov 6 · in 71 days · 1 company | |||||
| ALXO | ALX Oncology Holdings Inc. | Oncology | $276.55M | −0.99% | |
| Monday, Nov 9 · in 74 days · 3 companies | |||||
| OLMA | Olema Pharmaceuticals, Inc. | Oncology | $954.60M | −9.16% | |
| 0IL8.L | Kyntra Bio, Inc. | Oncology | $512.46M | +1.50% | |
| CATX | Perspective Therapeutics, Inc. | Oncology | $375.56M | +16.67% | |
| Tuesday, Nov 10 · in 75 days · 2 companies | |||||
| BCAX | Bicara Therapeutics Inc. | Oncology | $1.63B | −11.61% | |
| TARA | Protara Therapeutics, Inc. | Oncology | $234.61M | −1.73% | |
| Wednesday, Nov 11 · in 76 days · 2 companies | |||||
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Oncology | $751.23M | +7.09% | |
| PRLD | Prelude Therapeutics Incorporated | Oncology | $524.86M | +69.41% | |
| Thursday, Nov 12 · in 77 days · 11 companies | |||||
| AKTS | Aktis Oncology, Inc. | Oncology | $1.48B | +10.24% | |
| CADL | Candel Therapeutics, Inc. | Oncology | $1.04B | +36.55% | |
| AURA | Aura Biosciences, Inc. | Oncology | $810.97M | +9.22% | |
| MNPR | Monopar Therapeutics Inc. | Oncology | $747.47M | +0.44% | |
| EIKN | Eikon Therapeutics, Inc. | Oncology | $679.77M | +27.02% | |
| SGMT | Sagimet Biosciences Inc. | Oncology | $639.61M | +38.12% | |
| FENC | Fennec Pharmaceuticals Inc. | Oncology | $410.64M | +14.69% | |
| FRX.TO | Fennec Pharmaceuticals Inc. | Oncology | $392.65M | +5.73% | |
| MGNX | MacroGenics, Inc. Common Stock | Oncology | $265.63M | +4.25% | |
| GLSI | Greenwich LifeSciences, Inc. | Oncology | $258.04M | +38.32% | |
| NTHI | NeOnc Technologies Holdings, Inc. | Oncology | $122.16M | +36.92% | |
| Friday, Nov 13 · in 78 days · 2 companies | |||||
| INBX | Inhibrx Biosciences, Inc. | Oncology | $1.81B | +48.84% | |
| HURA | TuHURA Biosciences, Inc. | Oncology | $130.00M | −7.69% | |
| Monday, Nov 16 · in 81 days · 2 companies | |||||
| AVBP | ArriVent BioPharma, Inc. | Oncology | $1.55B | +3.95% | |
| ONCY | Oncolytics Biotech Inc. | Oncology | $109.84M | +7.68% | |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.